William Grossman insider trades
Open-market stock purchases and sales by William Grossman, Interim Chief Medical Officer at enGene Therapeutics Inc, from SEC Form 4 filings since Feb 5, 2018.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +208%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | ENGN enGene Therapeutics Inc | Bought (not open market) | — |
| Jun 16, 2026 | ENGN enGene Therapeutics Inc | Bought (not open market) | — |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $599K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $291K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $158K |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |